Trials / Terminated
TerminatedNCT01149252
Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis
Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis.
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Trima, Israel Pharmaceutical Products · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of a new product, Psoralait, as compared to a placebo in the treatment of psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Psoralait | Cream to be used as instructed. |
| OTHER | Placebo cream. | Cream to be used as instructed |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2010-06-23
- Last updated
- 2014-12-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01149252. Inclusion in this directory is not an endorsement.